CLEARFLOW, Inc

CLEARFLOW, Inc has raised $4.4M in total funding. The most recent round was Seed.

CLEARFLOW, Inc is headquartered in Irvine, CA.

Blood and clots can pool and clog chest drains after cardiac surgery, causing Retained Blood Syndrome, atrial fibrillation, and other complications.

ClearFlow makes PleuraFlow, an Active Clearance Technology chest tube system that actively keeps chest drains clear after surgery, plus ClearFix for rigid sternal fixation.

A cited clinical study reports adding PleuraFlow's Active Chest Tube Clearance to a cardiac ERAS program cut Retained Blood Syndrome by 41%, postoperative atrial fibrillation by 17%, and ICU time by 30%, and the technology is protected by a family of US and foreign patents.

Founded in 2007 by cardiothoracic surgeon Dr. Edward Boyle and Paul Molloy to develop anti-occlusion surgical drainage devices; the Anaheim-based company's PleuraFlow system was later distributed exclusively in the US by Maquet Medical Systems.